Flottmann, F.
van Horn, N. http://orcid.org/0000-0001-5764-1982
Maros, M. E.
McDonough, R.
Deb-Chatterji, M.
Alegiani, A.
Thomalla, G.
Hanning, U.
Fiehler, J.
Brekenfeld, C.
,
Funding for this research was provided by:
Universitätsklinikum Hamburg-Eppendorf (UKE)
Article History
Received: 7 January 2021
Accepted: 22 May 2021
First Online: 30 June 2021
Conflict of interest
: G. Thomalla: unrelated consultancy for Acandis, Stryker; payment for lectures including service on “speakers bureaus”: Bayer, Bristol Myers Squibb, Boehringer Ingelheim, Daiichi Sankyo. J. Fiehler: unrelated consultancy for Acandis, Boehringer Ingelheim, Cerenovus, Covidien, Evasc Neurovascular, MD-Clinicals, Medtronic, Medina, MicroVention, Penumbra, Route 92 Medical, Stryker, Transverse Medical; grants/grants pending: MicroVention, Medtronic, Stryker, Cerenovus. M.E. Maros: funding from the German Federal Ministry for Economic Affairs and Energy within the scope of Zentrales Innovationsprogramm Mittelstand (ZF 4514602TS8). Unrelated consultancy for Smart Reporting and Siemens Healthineers. F. Flottmann, N. van Horn, R. McDonough, M. Deb-Chatterji, A. Alegiani, U. Hanning and C. Brekenfeld declare that they have no competing interests.